Shuangshuang Lu

5PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 13, 2025
Ectopic HLA-II Expression in ESCC: Exploration of Its Relationship with Neoantigen Burden and Patient Survival.

Yupei Ji, Zhizhong Wang, Zhenguo Cheng

|Aug 11, 2025
The Application of iPSCs in Tumour Immunotherapy.

Peinan Chen, Jian Gao, Jianing Feng

|Jul 29, 2025
Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma.

Chenglin Zhang, Yanyan Liu, Haoran Guo

|Dec 15, 2021
Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer.

Dujuan Cao, Qianqian Song, Junqi Li

|Feb 10, 2021
Chaperone-mediated autophagy affects tumor cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.

Dujuan Cao, Danyang Shan, Wenli Yan

Pageof 1

Frequent Collaborators

1 joint publications

Lei Huang

1 joint publications

Yupei Ji

1 joint publications

Renato Baleeiro

1 joint publications

Louisa S Chard Dunmall